Literature DB >> 2471736

Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies.

S C Ying1, H Gewurz, C M Kinoshita, L A Potempa, J N Siegel.   

Abstract

Multiple mAb to human C-reactive protein (CRP) were prepared which reacted preferentially with either native CRP, modified CRP (expressing "neo-CRP" determinants) or both forms of the molecule. These mAb were divided into four groups according to their binding characteristics to various CRP preparations and CRP peptides by using a combination of ELISA, dot blot, and Western blot assays; they were further characterized based upon their reactivity with CRP in the presence of calcium and inhibition by phosphorylcholine. The first group consisted of mAb that reacted only with native CRP, and served to define four distinct native CRP epitopes. The second group consisted of mAb that reacted with native CRP and also with CRP modified by direct immobilization on polystyrene plates, urea-chelation or SDS treatment in the absence of calcium, thus identifying a fifth native CRP epitope; these mAb displayed significantly greater reactivity with native than with modified CRP. The third group included mAb that reacted only with modified CRP and with the larger amino-terminal fragment (residues 1-146) of pronase-cleaved CRP. The fourth group included mAb that reacted only with modified CRP and with the smaller carboxyl-terminal fragment (residues 147-206) of pronase-cleaved CRP; most of these antibodies also reacted with the carboxyl-terminal octapeptide (residues 199-206) of CRP. These experiments have identified mAb that react preferentially with distinct conformational and sequence-determined epitopes of native and modified forms of the CRP molecule, respectively; provide partial identification of the epitopes with which they interact; point to the presence of at least five epitopes on native CRP and at least three epitopes on modified CRP; and provide antibodies suitable for identification and quantitation of native and modified forms of CRP. The mAb directed against neo-CRP epitopes may help identify the presence of this pentraxin and antigenically-related proteins at previously unappreciated sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein.

Authors:  Hai-Yun Li; Jing Wang; Fan Meng; Zhe-Kun Jia; Yang Su; Qi-Feng Bai; Ling-Ling Lv; Fu-Rong Ma; Lawrence A Potempa; Yong-Bin Yan; Shang-Rong Ji; Yi Wu
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

2.  C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP.

Authors:  Min S Wang; Joshua C Black; Michelle K Knowles; Scott M Reed
Journal:  Anal Bioanal Chem       Date:  2011-07-02       Impact factor: 4.142

3.  Carbohydrate ligands of human C-reactive protein: binding of neoglycoproteins containing galactose-6-phosphate and galactose-terminated disaccharide.

Authors:  Reiko T Lee; Yuan C Lee
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

4.  Studies on the interactions between C-reactive protein and complement proteins.

Authors:  Adrienn Bíró; Zita Rovó; Diana Papp; László Cervenak; Lilian Varga; George Füst; Nicole M Thielens; Gérard J Arlaud; Zoltán Prohászka
Journal:  Immunology       Date:  2007-01-18       Impact factor: 7.397

5.  Antibodies against C-reactive protein cross-react with 60-kilodalton heat shock proteins.

Authors:  Katalin Udvarnoki; László Cervenak; Katalin Uray; Ferenc Hudecz; Imre Kacskovics; Ralf Spallek; Mahavir Singh; George Füst; Zoltán Prohászka
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

6.  Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis.

Authors:  Qiu-Yu Li; Hai-Yun Li; Ge Fu; Feng Yu; Yi Wu; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

7.  C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis.

Authors:  Lin Zhang; Shan-Hui Liu; Tyler T Wright; Zhi-Yuan Shen; Hai-Yun Li; Wei Zhu; Lawrence A Potempa; Shang-Rong Ji; Alexander J Szalai; Yi Wu
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

8.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

9.  Complement factor H binds to denatured rather than to native pentameric C-reactive protein.

Authors:  Svetlana Hakobyan; Claire L Harris; Carmen W van den Berg; Maria Carmen Fernandez-Alonso; Elena Goicoechea de Jorge; Santiago Rodriguez de Cordoba; German Rivas; Palma Mangione; Mark B Pepys; B Paul Morgan
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

10.  Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species.

Authors:  S C Ying; J J Marchalonis; A T Gewurz; J N Siegel; H Jiang; B E Gewurz; H Gewurz
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.